R. Scott Wright

25.6k citations
145 papers · 20.1k · 17 hit papers · h-index 55

Impact in

Papers in

R. Scott Wright

139 papers receiving 19.1k citations

R. Scott Wright's Hit Papers

Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial 2024 · 59 citations
590+6+12Years since publication50010001.5k

Peers

R. Scott Wright
Comparison fields: 5 of 170
  • Cardiology and Cardiovascular Medicine 8.9k
  • Internal Medicine 576
  • Surgery 6.1k
  • Radiology, Nuclear Medicine and Imaging 2.8k
  • Endocrinology, Diabetes and Metabolism 1.8k
Replace Udo Sechtem with:
Udo Sechtem Germany
Pasquale Perrone Filardi Italy
John A. Goudevenos Greece
Jean G. MacFadyen United States
Francisco Antônio Helfenstein Fonseca Brazil
Heinz Drexel Austria
Daniel Pella Slovakia
David D. Waters United States
Alberto J. Lorenzatti United States
Borislava Mihaylova United Kingdom
R. Scott Wright relative to Udo Sechtem Germany Udo Sechtem's profile →
Citations per field
00.5×2×3×4×4.6×
Udo Sechtem · 1×
Citations per year

Countries citing papers authored by R. Scott Wright

Since Specialization
Citations

This map shows the geographic impact of R. Scott Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Scott Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Scott Wright more than expected).

Fields of papers citing papers by R. Scott Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Scott Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Scott Wright. The network helps show where R. Scott Wright may publish in the future.

Co-authors

The 25 scholars most cited alongside R. Scott Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. Scott Wright Line = papers co-authored together R. Scott Wright links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Hit paper breakdown →
20121686
2
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
Hit paper breakdown →
20071529
3
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
Hit paper breakdown →
20071268
4
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Hit paper breakdown →
20201208
5
Systematic Review: Transient Left Ventricular Apical Ballooning: A Syndrome That Mimics ST-Segment Elevation Myocardial Infarction
Hit paper breakdown →
20041193
6
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
Hit paper breakdown →
2012923
7
Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
Hit paper breakdown →
2017814
8
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
Hit paper breakdown →
2013778
9
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
Hit paper breakdown →
2020661
10 2002499
11 2004482
12 2007443
13 2004441
14
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
Hit paper breakdown →
2011431
15
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
Hit paper breakdown →
2012407
16
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
Hit paper breakdown →
2021399
17 2020338
18
Safety Update
Hit paper breakdown →
2020326
19 2011300
20 2011298

About R. Scott Wright

R. Scott Wright is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Surgery, Infectious Diseases and Obstetrics and Gynecology, having authored 145 papers that have together received 20.1k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (28 papers), Acute Myocardial Infarction Research (25 papers), Cardiac Imaging and Diagnostics (24 papers), COVID-19 Clinical Research Studies (11 papers), Cardiovascular Function and Risk Factors (11 papers), Cardiac electrophysiology and arrhythmias (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (8.9k citations), Internal Medicine (576 citations), Surgery (6.1k citations), Radiology, Nuclear Medicine and Imaging (2.8k citations) and Endocrinology, Diabetes and Metabolism (1.8k citations). R. Scott Wright has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Lawrence A. Leiter, David G. Kallend, Kausik Kumar Ray, John J.P. Kastelein, A. Michael Lincoff, NANETTE KASS WENGER, Donald E. Casey, Eric D. Peterson, Jeffrey L. Anderson and Cynthia D. Adams. Their work appears in journals such as Mayo Clinic Proceedings, Journal of the American College of Cardiology, The American Journal of Cardiology, Circulation and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact